FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2123670278> ?p ?o ?g. }

• W2123670278 endingPage "628" @default.
• W2123670278 startingPage "622" @default.
• W2123670278 abstract "We examined whether antibodies (present in sera from patients with Graves' disease) might be directed against a connective tissue cellular component of the anatomical regions affected in the peripheral manifestations of that disease. Accordingly, we performed immunoblot analyses of cultured retroocular and pretibial fibroblasts. Retroocular connective tissue was obtained during orbital decompression surgery (n = 7) and at autopsy from normal individuals (n = 2). Pretibial skin biopsies were obtained from patients with pretibial dermopathy (n = 3) and at autopsy (n = 2). In addition, biopsies from other regions [extraocular muscle (n = 6), thyroid (n = 2), and abdominal skin (n = 3)] were also collected at surgery or autopsy. Serum samples were obtained from patients with severe Graves' ophthalmopathy (n = 31), hyperthyroid Graves' disease without overt ophthalmopathy (n = 13), nodular thyroid disease (n = 7), Hashimoto's thyroiditis (n = 7), rheumatoid arthritis (n = 5), and systemic lupus erythematosus (n = 3) and from normal individuals (n = 33). Electrophoresed fibroblast proteins were immunoblotted with 1:100 dilutions of sera using an antihuman immunoglobulin G-alkaline phosphatase conjugate. Antibodies against a 23kDa fibroblast protein were present in the sera from 24 of 44 (56%) of patients with Graves' disease with or without ophthalmopathy, 0 of 7 nodular thyroid disease, 0 of 7 Hashimoto's thyroiditis, 0 of 5 rheumatoid arthritis, 0 of 3 systemic lupus erythematosus, and 5 of 33 (15%) normal subjects. Significant differences in the observed frequency of antibodies existed between the Graves' disease group and the normal control group (P less than 0.01) or those patients with the other conditions (P less than 0.01). This 23kDa antigen was apparent in fibroblasts derived from individuals with Graves' disease as well as normal individuals and was present in fibroblasts from all anatomical sites studied. It was the sole protein uniquely recognized by sera from patients with Graves' disease. However, this serum reactivity did not appear to be related to the presence of clinically overt ophthalmopathy or pretibial dermopathy. Subcellular localization studies disclosed that the antigen was present in the supernatant but not the pellet resulting from a 100,000 x g centrifugation of whole cell sonicates. Antibodies against a 23kDa fibroblast protein are present in the majority of sera from patients with Graves' disease and rarely in sera from either normal individuals or those with other thyroid disorders or autoimmune diseases. Our results suggest the possibility that antibodies directed against this fibroblast antigen may be related to the developm" @default.
• W2123670278 created "2016-06-24" @default.
• W2123670278 creator A5007679045 @default.
• W2123670278 creator A5039851000 @default.
• W2123670278 creator A5049027204 @default.
• W2123670278 creator A5077112559 @default.
• W2123670278 date "1989-09-01" @default.
• W2123670278 modified "2023-10-16" @default.
• W2123670278 title "Presence of Antibodies in the Sera of Patients with Graves' Disease Recognizing a 23 Kilodalton Fibroblast Protein*" @default.
• W2123670278 cites W1965113827 @default.
• W2123670278 cites W1975884151 @default.
• W2123670278 cites W1978856295 @default.
• W2123670278 cites W1981034567 @default.
• W2123670278 cites W1994792951 @default.
• W2123670278 cites W2014937081 @default.
• W2123670278 cites W2016333772 @default.
• W2123670278 cites W2029469100 @default.
• W2123670278 cites W2030354587 @default.
• W2123670278 cites W2036942996 @default.
• W2123670278 cites W2050754805 @default.
• W2123670278 cites W2055348146 @default.
• W2123670278 cites W2059385984 @default.
• W2123670278 cites W2067774813 @default.
• W2123670278 cites W2072966276 @default.
• W2123670278 cites W2077931187 @default.
• W2123670278 cites W2094138540 @default.
• W2123670278 cites W2100837269 @default.
• W2123670278 cites W2101108802 @default.
• W2123670278 cites W2163219777 @default.
• W2123670278 cites W233462812 @default.
• W2123670278 cites W2338683883 @default.
• W2123670278 cites W262999132 @default.
• W2123670278 cites W602045129 @default.
• W2123670278 cites W73432558 @default.
• W2123670278 cites W95357200 @default.
• W2123670278 doi "https://doi.org/10.1210/jcem-69-3-622" @default.
• W2123670278 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2760173" @default.
• W2123670278 hasPublicationYear "1989" @default.
• W2123670278 type Work @default.
• W2123670278 sameAs 2123670278 @default.
• W2123670278 citedByCount "62" @default.
• W2123670278 countsByYear W21236702782012 @default.
• W2123670278 countsByYear W21236702782013 @default.
• W2123670278 countsByYear W21236702782019 @default.
• W2123670278 crossrefType "journal-article" @default.
• W2123670278 hasAuthorship W2123670278A5007679045 @default.
• W2123670278 hasAuthorship W2123670278A5039851000 @default.
• W2123670278 hasAuthorship W2123670278A5049027204 @default.
• W2123670278 hasAuthorship W2123670278A5077112559 @default.
• W2123670278 hasConcept C126322002 @default.
• W2123670278 hasConcept C134018914 @default.
• W2123670278 hasConcept C142724271 @default.
• W2123670278 hasConcept C159654299 @default.
• W2123670278 hasConcept C202751555 @default.
• W2123670278 hasConcept C203014093 @default.
• W2123670278 hasConcept C2775915377 @default.
• W2123670278 hasConcept C2776153627 @default.
• W2123670278 hasConcept C2776652619 @default.
• W2123670278 hasConcept C2776670291 @default.
• W2123670278 hasConcept C2777575956 @default.
• W2123670278 hasConcept C2778674544 @default.
• W2123670278 hasConcept C2778696486 @default.
• W2123670278 hasConcept C2779075594 @default.
• W2123670278 hasConcept C2779134260 @default.
• W2123670278 hasConcept C2779504383 @default.
• W2123670278 hasConcept C2780381497 @default.
• W2123670278 hasConcept C518705261 @default.
• W2123670278 hasConcept C526584372 @default.
• W2123670278 hasConcept C55493867 @default.
• W2123670278 hasConcept C71924100 @default.
• W2123670278 hasConcept C86803240 @default.
• W2123670278 hasConceptScore W2123670278C126322002 @default.
• W2123670278 hasConceptScore W2123670278C134018914 @default.
• W2123670278 hasConceptScore W2123670278C142724271 @default.
• W2123670278 hasConceptScore W2123670278C159654299 @default.
• W2123670278 hasConceptScore W2123670278C202751555 @default.
• W2123670278 hasConceptScore W2123670278C203014093 @default.
• W2123670278 hasConceptScore W2123670278C2775915377 @default.
• W2123670278 hasConceptScore W2123670278C2776153627 @default.
• W2123670278 hasConceptScore W2123670278C2776652619 @default.
• W2123670278 hasConceptScore W2123670278C2776670291 @default.
• W2123670278 hasConceptScore W2123670278C2777575956 @default.
• W2123670278 hasConceptScore W2123670278C2778674544 @default.
• W2123670278 hasConceptScore W2123670278C2778696486 @default.
• W2123670278 hasConceptScore W2123670278C2779075594 @default.
• W2123670278 hasConceptScore W2123670278C2779134260 @default.
• W2123670278 hasConceptScore W2123670278C2779504383 @default.
• W2123670278 hasConceptScore W2123670278C2780381497 @default.
• W2123670278 hasConceptScore W2123670278C518705261 @default.
• W2123670278 hasConceptScore W2123670278C526584372 @default.
• W2123670278 hasConceptScore W2123670278C55493867 @default.
• W2123670278 hasConceptScore W2123670278C71924100 @default.
• W2123670278 hasConceptScore W2123670278C86803240 @default.
• W2123670278 hasIssue "3" @default.
• W2123670278 hasLocation W21236702781 @default.
• W2123670278 hasLocation W21236702782 @default.
• W2123670278 hasOpenAccess W2123670278 @default.
• W2123670278 hasPrimaryLocation W21236702781 @default.

• next